Purple Biotech will present data from the Randomized Phase 2 CM24 Pancreatic Cancer Study in a Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting which takes place May 31 – June 4, 2024 in Chicago, Illinois.

Purple Biotech will present data from the Randomized Phase 2 CM24 Pancreatic Cancer Study in a Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting which takes place May 31 – June 4, 2024 in Chicago, Illinois.

in May 15, 2024